好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Dispatches from the Concussion Field: ACRM'S Revised Mild TBI Diagnostic Criteria and CARF International's New Concussion Rehabilitation Program Accreditation Standards
Neuro Trauma and Critical Care
P2 - Poster Session 2 (11:45 AM-12:45 PM)
14-020

To provide education on two new resources available to the field to enhance the care provided to individuals with lived experience of concussion. 

 

The Mild TBI Task Force of the American Congress of Rehabilitation Medicine has recently updated the diagnostic criteria for mild traumatic brain injury (mTBI). This discussion will provide an overview of these activities and present the consensus diagnostic criteria for mild TBI. 

CARF International has worked with the field to create the first Concussion Rehabilitation Program standards, which support the return of individuals to participation in their life roles, including, but not limited to, return to school, return to work, and return to sport. By promoting interdisciplinary, evidence-based, and person-centered care, these standards will promote self-management, self-advocacy, and prevention of future concussion.
ACRM's revision of the Mild TBI Diagnostic Criteria included rapid evidence reviews, an expert survey (to rate the diagnostic importance of clinical signs, symptoms, test findings, and contextual factors), public and stakeholder engagement, and a Delphi consensus process with an international, interdisciplinary panel of clinician-scientists. The creation of CARF's Concussion Rehabilitation Program Standards included interviews with different types of stakeholders across the field including persons served, providers, payers and others. An international, interdisciplinary committee created draft standards which were shared during a public field review and that feedback was integrated into the final Concussion Rehabilitation Program standards.
ACRM's revised Mild TBI Diagnostic Criteria were published in 2023 and are available to the public, and CARF International's Concussion Rehabilitation Program standards are part of the 2024 CARF Medical Rehabilitation Standards Manual and will be available for accreditation beginning July 2024. 
These two resources can be used to improve the identification of individuals with concussion and also provide guidance on how Concussion Rehabilitation Programs enhance the lives of individuals with lived experience of concussion. 
Authors/Disclosures
Christopher Giza, MD, FAAN (UCLA, Depts of Pediatrics and Neurosurgery)
PRESENTER 		Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
Gerard A. Gioia, MD Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care.
Michael M. Yochelson, MD, FAAN (Shepherd Center) Dr. Yochelson has stock in CVS. Dr. Yochelson has stock in Pfizer. The institution of Dr. Yochelson has received research support from AbbVie.
Terrence Carolan (CARF International) No disclosure on file